Evidence map›Paper›PMID 26842474›Full record

ArticleJournal of virology2016

Expansion of Inefficient HIV-Specific CD8 T Cells during Acute Infection.

Michael A Eller, Nilu Goonetilleke, Boonrat Tassaneetrithep, Leigh Anne Eller, Margaret C Costanzo, Susan Johnson, Michael R Betts, Shelly J Krebs, Bonnie M Slike, Sorachai Nitayaphan and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Increased CD8Immunology · 2025
    Article
  4. Article
  5. Article
  6. Association of serum vitamin BJournal of family medicine and primary care · 2022
    Article
  7. Article
  8. Article
  9. An expanded population of CD8Frontiers in cell and developmental biology · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Specificity of CD8Vaccines · 2020
    Article
  14. Article
  15. Terminal Effector CD8 T Cells Defined by an IKZF2Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  16. Expansion of Stem Cell-Like CD4Journal of virology · 2019
    Observational
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 5 countries.

Michael A EllerU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Nilu GoonetillekeDepartment of Immunology & Microbiology, University of North Carolina, Chapel Hill, North Carolina, USA.
Boonrat TassaneetrithepOffice for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Leigh Anne EllerU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Margaret C CostanzoU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Susan JohnsonU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Michael R BettsDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Shelly J KrebsU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Bonnie M SlikeU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Sorachai NitayaphanDepartment of Retrovirology, United States Army Medical Component, Armed Forces Research Institute of Medical Sciences (USAMC-AFRIMS), Bangkok, Thailand.
Kathleen RonoWalter Reed Project-Kenya, Kericho, Kenya.
Sodsai TovanabutraU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Lucas MagangaWalter Reed Program-Tanzania, Mbeya, Tanzania.
Hannah KibuukaMakerere University Walter Reed Project, Kampala, Uganda.
Linda JagodzinskiU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Sheila PeelU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Morgane RollandU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Mary A MarovichU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Jerome H KimU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Nelson L MichaelU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Merlin L RobbU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Hendrik StreeckU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA Hendrik.streeck@uk-essen.de.
Walter Reed Army Institute of Research · USHenry M. Jackson Foundation · USArmed Forces Research Institute of Medical Science · THMahidol University · THMakerere University Walter Reed Project · UGUniversity of Duisburg-Essen · DEUniversity of North Carolina at Chapel Hill · USUniversity of Pennsylvania · US

Funding

T cell functionality and control of HIV infectionR01AI076066 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BETTS, MICHAEL R · 2008 to 2017
$4.6M
NIAID NIH HHS R01 AI076066
6 · The paper itself

Abstract

unlabelledAttrition within the CD4(+)T cell compartment, high viremia, and a cytokine storm characterize the early days after HIV infection. When the first emerging HIV-specific CD8(+)T cell responses gain control over viral replication it is incomplete, and clearance of HIV infection is not achieved even in the rare cases of individuals who spontaneously control viral replication to nearly immeasurably low levels. Thus, despite their partial ability to control viremia, HIV-specific CD8(+)T cell responses are insufficient to clear HIV infection. Studying individuals in the first few days of acute HIV infection, we detected the emergence of a unique population of CD38(+)CD27(-)CD8(+)T cells characterized by the low expression of the CD8 receptor (CD8(dim)). Interestingly, while high frequencies of HIV-specific CD8(+)T cell responses occur within the CD38(+)CD27(-)CD8(dim)T cell population, the minority populations of CD8(bright)T cells are significantly more effective in inhibiting HIV replication. Furthermore, the frequency of CD8(dim)T cells directly correlates with viral load and clinical predictors of more rapid disease progression. We found that a canonical burst of proliferative cytokines coincides with the emergence of CD8(dim)T cells, and the size of this population inversely correlates with the acute loss of CD4(+)T cells. These data indicate, for the first time, that early CD4(+)T cell loss coincides with the expansion of a functionally impaired HIV-specific CD8(dim)T cell population less efficient in controlling HIV viremia. IMPORTANCE: A distinct population of activated CD8(+)T cells appears during acute HIV infection with diminished capacity to inhibit HIV replication and is predictive of viral set point, offering the first immunologic evidence of CD8(+)T cell dysfunction during acute infection.

Indexed as

Acute DiseaseAdolescentAdultCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell ProliferationEpitopesFemaleHIV InfectionsHumansImmunophenotypingLymphocyte CountMaleMiddle AgedT-Lymphocyte SubsetsViral LoadEpitopes

Identifiers

PMID26842474
PMCPMC4810544
OpenAlexW2269731566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.